Suppr超能文献

载诺氟沙星的电纺支架:蒙脱石纳米复合材料与游离药物

Norfloxacin-Loaded Electrospun Scaffolds: Montmorillonite Nanocomposite vs. Free Drug.

作者信息

Faccendini Angela, Ruggeri Marco, Miele Dalila, Rossi Silvia, Bonferoni Maria Cristina, Aguzzi Carola, Grisoli Pietro, Viseras Cesar, Vigani Barbara, Sandri Giuseppina, Ferrari Fraanca

机构信息

Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.

Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy. University of Granada, Campus of Cartuja, 18071 s/n Granada, Spain.

出版信息

Pharmaceutics. 2020 Apr 4;12(4):325. doi: 10.3390/pharmaceutics12040325.

Abstract

Infections in nonhealing wounds remain one of the major challenges. Recently, nanomedicine approach seems a valid option to overcome the antibiotic resistance mechanisms. The aim of this study was the development of three types of polysaccharide-based scaffolds (chitosan-based (CH), chitosan/chondroitin sulfate-based (CH/CS), chitosan/hyaluronic acid-based (CH/HA)), as dermal substitutes, to be loaded with norfloxacin, intended for the treatment of infected wounds. The scaffolds have been loaded with norfloxacin as a free drug (N scaffolds) or in montmorillonite nanocomposite (H-hybrid-scaffolds). Chitosan/glycosaminoglycan (chondroitin sulfate or hyaluronic acid) scaffolds were prepared by means of electrospinning with a simple, one-step process. The scaffolds were characterized by 500 nm diameter fibers with homogeneous structures when norfloxacin was loaded as a free drug. On the contrary, the presence of nanocomposite caused a certain degree of surface roughness, with fibers having 1000 nm diameters. The presence of norfloxacin-montmorillonite nanocomposite (1%) caused higher deformability (90%-120%) and lower elasticity (5-10 mN/cm), decreasing the mechanical resistance of the systems. All the scaffolds were proven to be degraded via lysozyme (this should ensure scaffold resorption) and this sustained the drug release (from 50% to 100% in 3 days, depending on system composition), especially when the drug was loaded in the scaffolds as a nanocomposite. Moreover, the scaffolds were able to decrease the bioburden at least 100-fold, proving that drug loading in the scaffolds did not impair the antimicrobial activity of norfloxacin. Chondroitin sulfate and montmorillonite in the scaffolds are proven to possess a synergic performance, enhancing the fibroblast proliferation without impairing norfloxacin's antimicrobial properties. The scaffold based on chondroitin sulfate, containing 1% norfloxacin in the nanocomposite, demonstrated adequate stiffness to sustain fibroblast proliferation and the capability to sustain antimicrobial properties to prevent/treat nonhealing wound infection during the healing process.

摘要

难愈合伤口的感染仍然是主要挑战之一。近来,纳米医学方法似乎是克服抗生素耐药机制的有效选择。本研究的目的是开发三种基于多糖的支架(壳聚糖基(CH)、壳聚糖/硫酸软骨素基(CH/CS)、壳聚糖/透明质酸基(CH/HA))作为皮肤替代物,负载诺氟沙星用于治疗感染伤口。支架已负载诺氟沙星,以游离药物形式(N支架)或负载于蒙脱石纳米复合材料中(H-混合支架)。壳聚糖/糖胺聚糖(硫酸软骨素或透明质酸)支架通过简单的一步电纺工艺制备。当诺氟沙星以游离药物形式负载时,支架的特征是具有直径500nm且结构均匀的纤维。相反,纳米复合材料的存在导致一定程度的表面粗糙度,纤维直径为1000nm。诺氟沙星-蒙脱石纳米复合材料(1%)的存在导致更高的可变形性(90%-120%)和更低的弹性(5-10mN/cm),降低了系统的机械抗性。所有支架均被证明可通过溶菌酶降解(这应确保支架吸收),并维持药物释放(3天内从50%至100%,取决于系统组成),尤其是当药物以纳米复合材料形式负载于支架中时。此外,支架能够将生物负荷降低至少100倍,证明支架负载药物不会损害诺氟沙星的抗菌活性。支架中的硫酸软骨素和蒙脱石被证明具有协同性能,可增强成纤维细胞增殖而不损害诺氟沙星的抗菌特性。基于硫酸软骨素的支架,在纳米复合材料中含有1%诺氟沙星,表现出足够的硬度以维持成纤维细胞增殖,并具有维持抗菌特性的能力,可在愈合过程中预防/治疗难愈合伤口感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38ea/7238150/20223651a8f4/pharmaceutics-12-00325-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验